Harbin Gloria Pharmaceuticals Co.,Ltd Fundamental Rankings

This page is comprehensive fundamental data for Harbin Gloria Pharmaceuticals Co.,Ltd. Fundamentals are ordered by how Harbin Gloria Pharmaceuticals Co.,Ltd ranks compared to other companies (ordered high to low). All money values are in CNY. All data is powered by Quandl.

Cite in Wikipedia:

Indicator Value n/price Rank Date Historic
Goodwill3,429,116,0920.1934552015-06-30historic
Productive biological assets82,4500.0572015-06-30historic
Proceeds from sell of investment1,713,010,0000.09664802015-06-30historic
Other non-current liabilities14,854,0008.4E-41162015-06-30historic
Long term accounts payable313,149,1060.017671262015-06-30historic
Cash paid for other investing activities295,840,0000.016691282015-06-30historic
Minority interests gain16,967,7989.6E-42332015-06-30historic
Comprehensive income attributable to minority shareholders16,967,7989.6E-42342015-06-30historic
Operating profit396,683,5540.022382352015-06-30historic
Net income340,662,4690.019222382015-06-30historic
Total profit410,269,6960.023142512015-06-30historic
Total comprehensive income340,662,4690.019222672015-06-30historic
Net cashflow from financing activities694,277,5470.039173292015-06-30historic
Cash paid for other financing activities49,086,2690.002773362015-06-30historic
Total non-current assets6,062,222,1900.341993802015-06-30historic
Selling expenses172,818,4860.009753832015-06-30historic
Cash paid for taxes251,164,6290.014173862015-06-30historic
Short term borrowings1,550,000,0000.087443872015-06-30historic
Other payables345,045,4090.019473992015-06-30historic
Disposal of fixed assets and others674,5394.0E-54382015-06-30historic
Minority interest229,695,8220.012964402015-06-30historic
Intangible assets444,489,9610.025084412015-06-30historic
Financial expenses37,130,2890.002095552015-06-30historic
Cash inflows from financing activities1,339,129,4720.075545692015-06-30historic
Prepayment165,571,4820.009345822015-06-30historic
Interests payable2,163,3331.2E-45892015-06-30historic
Total liabilities3,866,806,5860.218145912015-06-30historic
Cash paid for dividends, profits or interests115,765,6550.006536302015-06-30historic
Fixed assets1,506,522,6860.084996342015-06-30historic
Other current assets49,783,3480.002817002015-06-30historic
Purchases of fixed assets and others104,783,8780.005917022015-06-30historic
Other receivables64,806,8970.003667132015-06-30historic
Total liabilities and equity7,368,229,2960.415667422015-06-30historic
Capital reserve1,270,330,9920.071667942015-06-30historic
Cash inflows from operating activities1,514,923,9530.085468142015-06-30historic
Refunds of taxes223,5161.0E-58222015-06-30historic
Long term equity investment3,000,0001.7E-48372015-06-30historic
Deferred tax assets21,712,7470.001228632015-06-30historic
Revenue1,264,605,3820.071348642015-06-30historic
Notes receivable11,398,0566.4E-48972015-06-30historic
Net cash and cash equivalents ending balance579,207,2400.032679182015-06-30historic
Cash outflows from operating activities1,154,421,1030.065129212015-06-30historic
Total cost of goods sold870,519,1720.049119762015-06-30historic
Diluted eps00.010402015-06-30historic
Accounts payable147,797,4930.0083411072015-06-30historic
Inventories227,074,2780.0128111072015-06-30historic
Non-operating loss162,5361.0E-511412015-06-30historic
Net change in cash-481,954,021-0.0271911412015-06-30historic
Payroll payable5,476,3423.1E-412072015-06-30historic
Net cash flows from investing activities-1,536,734,419-0.0866912802015-06-30historic